ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

10 links0 made here, not in the record9 judgments1 judge (the rules as one: Rule based)0 record changes seen
Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04747912Study of Chemotherapy-FreeInduction Regimen for Ph+Acute LymphoblasticLeukemia With InotuzumabOzogamicin (InO)University of ChicagoPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSPrecursor Cell Lymphoblasti…The registry's MeSH filing›As of now · Rule based · Main conditionMain conditionLeukemiaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSInotuzumab OzogamicinIntervention entry›As of now · Rule based · TestedTestedDasatinibIntervention entry›As of now · Rule based · TestedTestedDexamethasoneIntervention entry›As of now · Rule based · BackgroundBackgroundMethotrexateIntervention entry›As of now · Rule based · BackgroundBackgroundVincristineIntervention entry›As of now · Rule based · TestedTestedPonatinibIntervention entry›As of now · Rule based · TestedTestedMercaptopurineEntry “Purinethol (6-Mercaptopurine)”…›As of now · Rule based · TestedTestedPrednisoneIntervention entry›As of now · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Precursor Cell Lymphoblastic Leukemia-Lymphoma

From the registry record1 judgment on this link
Main condition (R9), from the registry to what was judged
RegistryPrecursor Cell Lymphoblastic Leukemia-Lymphoma, as filedthe registry files the study under it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
As of nowPrecursor Cell Lymphoblastic Leukemia-LymphomaRule based · main-condition ruleMain conditionCurrent
As of nowInotuzumab OzogamicinRule based · role ruleTestedCurrent
As of nowDasatinibRule based · role ruleTestedCurrent
As of nowDexamethasoneRule based · role ruleBackgroundCurrent
As of nowMethotrexateRule based · role ruleBackgroundCurrent
As of nowVincristineRule based · role ruleTestedCurrent
As of nowPonatinibRule based · role ruleTestedCurrent
As of nowMercaptopurineRule based · role ruleTestedCurrent
As of nowPrednisoneRule based · role ruleTestedCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.